HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Reata Pharmaceuticals, Inc. (RETA) Investors to Lead Plaintiff Opportunity in Securities Fraud Class Action
December 23, 2021 10:03 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. A securities fraud...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Reata Pharmaceuticals, Inc. (RETA) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
December 18, 2021 10:29 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 18, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. Visit:...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Reata Pharmaceuticals, Inc. (RETA) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
December 13, 2021 18:46 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. Visit:...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Reata Pharmaceuticals, Inc. (RETA) Investors to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
December 07, 2021 19:41 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Reata Pharmaceuticals, Inc. (NASDAQ: RETA) investors with significant losses to submit your losses now. Visit:...